PatrickWilliamBurkeMD

Clinical Lecturer, Dept of Internal Medicine, Division of Heme/Onc, University of Michigan

Dr. Burke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
University of ChicagoResidency, Internal Medicine, 2007 - 2010
Icahn School of Medicine at Mount SinaiClass of 2007

PubMed

7 citations
Successful reintroduction of blinatumomab in a patient with relapsed/refractory acute lymphoblastic leukemia following grade 4 cytokine release syndrome.
Bernard L. Marini, Yihan Sun, Patrick W. Burke, Anthony J. Perissinotti
Journal of Oncology Pharmacy Practice. 2018-01-01
19 citations
The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemia.
Vera Vulaj, Anthony J. Perissinotti, James R. Uebel, Victoria R Nachar, Gianni B. Scappaticci
Leukemia Research. 2018-07-01
106 citations
Acute lymphoblastic leukemia, version 2.2021
Patrick A. Brown, Bijal D. Shah, Anjali S. Advani, Patricia Aoun, Michael Boyer
Journal of the National Comprehensive Cancer Network. 2021-09-01

Abstracts/Posters

Multi-Center Retrospective Evaluation of High-Dose Cytarabine Based Induction Versus CPX-351 Induction in Patients with Secondary AML
Patrick W. Burke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019